Quebec Network Réseau Québécoise de l’Amyotrophie Spinale Joins NMD4C as Community of Practice Sub-Group

We are thrilled to announce that the Réseau Québécoise de l’Amyotrophie Spinale (RQAS), a network uniting rehabilitation clinicians across Quebec to advance the care of people with Spinal Muscular Atrophy (SMA) since 2022, has officially become a sub-group Community of Practice of the Neuromuscular Disease Network of Canada (NMD4C).

This marks an exciting milestone for both the NMD4C and RQAS members, offering significant new opportunities and resources.

 

By welcoming the RQAS, the NMD4C gains:

  • A well-established community of practice of 136+ members, including clinicians, researchers, and patient partners.
  • Stronger French-Canadian representation, ensuring diverse perspectives in care, research, and policy.
  • A proven model for clinician-driven collaboration, expanding best practices across neuromuscular diseases.

 

As a sub-group of the NMD4C, the RQAS will benefit from:

  • Greater access to support for research, training, and initiatives to improve neuromuscular care.
  • Enhanced organizational support, streamlining activities for greater efficiency.
  • A broader national network, fostering collaboration, knowledge-sharing, and innovation.

 

Through incorporating RQAS into NMD4C, we will continue our efforts to unify, support, and advance neuromuscular care and research across Canada. We look forward to working together to drive innovation and improve outcomes for individuals with neuromuscular diseases. If you have any questions, contact Community of Practice Manager, Dr Maria Masnata at <>

RQAS logo

Read next...

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

LEARNMD content update - February 2025

New Content Available in LEARNMD

LEARNMD is the NMD4C’s online educational platform, offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide. We’re excited to share what’s new on LEARNMD in February 2025!

2024 year in review

NMD4C 2024 Year in Review

This year in review outlines a collection of achievements from the network over the past year.

2025 NM fellowship funding recipients

NMD4C and MDC Award Fellowship Funding in NMD Research and Medicine

Together the Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are excited to announce the 2025 recipients of our neuromuscular fellowship funding competition to award postdoctoral fellowships in neuromuscular disease (NMD) research and clinical fellowships in neuromuscular medicine and electromyography!

Meet the Basic Science Trainee Committee

NMD4C Basic Science Trainee Committee Provides Leadership Opportunity for Next Generation of Neuromuscular Researchers

The newly-formed Basic Science Trainee Committee represents the interests of trainees within the network, offering an opportunity for professional growth for future leaders in neuromuscular research.

SMA Workshop Pic 2

NMD4C and MDC Host Second SMA Outcome Measure Training Workshop for Physiotherapists and Occupational Therapists Across Canada

The Spinal Muscular Atrophy (SMA) Motor Function Measures workshop organized by the NMD4C in collaboration with MDC took place in Montreal, Quebec on December 3rd, 2024 and was a resounding success. This workshop was established to harmonize assessment practices for the following SMA outcome measures across Canada